Chronic Kidney Disease Drug Gets a Name Drug Discovery & Development The U.S. Food & Drug Administration (FDA) has accepted the proposed proprietary trade name Triferic for the Rockwell Medical's investigational iron-delivery drug, previously known as soluble ferric pyrophosphate (SFP), which is intended for treating ... Rockwell Medical Announces FDA Acceptance of Triferic(TM) as Proprietary ... Rockwell Medical Has a 52 Week Low of $3.16 & a 52 Week High of $11.80 |
